Organization · Corporate Venture Capital
The Blue Venture Fund
The Blue Venture Fund is a corporate venture capital initiative based in Chicago, Illinois, focused on investing in healthcare technology, services, and clinical sciences. It collaborates with Blue Cross Blue Shield companies to enhance health outcomes and deliver value to patients.
Overview
What The Blue Venture Fund does
What The Blue Venture Fund is
The Blue Venture Fund is a corporate venture capital initiative based in Chicago, Illinois, focused on investing in healthcare technology, services, and clinical sciences. It collaborates with Blue Cross Blue Shield companies to enhance health outcomes and deliver value to patients.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Corporate Venture Capital
- Structured capabilities
- Funder
- Last reviewed
- May 6, 2026
Official channels
Find The Blue Venture Fund elsewhere
Open the official website or a supported primary organization account.
Capability profile
The Blue Venture Fund as a funder
Investment thesis
The Blue Venture Fund invests in healthcare companies that can improve outcomes, reduce costs, and create value for Blue Plan members and participating Blue Cross Blue Shield plans.
Focus narrative
The Blue Venture Fund targets investments in three key sub-sectors of healthcare: Healthcare Services, which aim to redesign care delivery and enhance patient experiences; Healthcare Technology, which develops technology and services to improve health plan operations; and Clinical companies that enhance medical care and decision-making. The fund is stage agnostic, investing from seed through growth and buyout.
Value beyond capital
The Blue Venture Fund offers more than just capital; it provides portfolio companies with access to commercialization opportunities through connections with Blue Plan executives, subject-matter experts, and advisory groups. This strategic support helps companies navigate the healthcare landscape and enhances their potential for success.
Focus and fit
- Stages
- Seed · Series A · Growth Equity · Friends and Family · Angel · Accelerator · Series B · Series C · Series D · Series E · Series F · Pre-IPO · Ipo · Secondary · Bridge · Recap
- Sectors
- Healthcare · Diagnostics
- Regions
- United States
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 30
Portfolio context
Notable portfolio companies include: Daymark Health, a tech-enabled cancer care platform; Noctrix Health, which develops therapy for restless legs syndrome; Humata Health, providing AI-enabled prior authorization automation; HealthEdge, a digital technology platform for payer operations; Somatus, focused on value-based kidney care; Wider Circle, a neighborhood-based health organization; Fort Health, a pediatric behavioral health provider; and InsightIn Health, a member engagement platform.
Common questions
What to know about The Blue Venture Fund
Upseed classifies The Blue Venture Fund under the Corporate Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
May 6, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.